Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Boston Scientific Corp (BSX) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 28,336,500
  • Shares Outstanding, K 1,360,740
  • Annual Sales, $ 7,477 M
  • Annual Income, $ -239 M
  • 36-Month Beta 1.09
  • Price/Sales 3.79
  • Price/Book 4.37

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.67 +4.78%
on 12/01/16
22.34 -7.74%
on 11/10/16
-1.64 (-7.37%)
since 11/08/16
3-Month
19.67 +4.78%
on 12/01/16
24.28 -15.12%
on 09/09/16
-3.87 (-15.81%)
since 09/08/16
52-Week
15.67 +31.53%
on 02/08/16
24.79 -16.86%
on 07/28/16
+1.88 (+10.04%)
since 12/08/15

Most Recent Stories

More News
Boston Scientific (BSX) Inks $75 Million Deal with Neovasc

Boston Scientific Corporation (BSX) recently inked a deal with specialty medical device company Neovasc Inc.

Neovasc and Boston Scientific Reach US$75 Million Agreement

Boston Scientific acquires tissue processing capabilities and takes equity stake in Neovasc -

Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities

Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire certain manufacturing assets and capabilities of the Neovasc, Inc., (NASDAQ: NVCN) (TSX: NVC) advanced biological...

Boston Scientific To Participate In Citi 2016 Global Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Citi 2016 Global Healthcare Conference on December 7 in New York City.

Sovos Compliance Wins Tekne Award for Innovation

The Minnesota High Tech Association (MHTA) announced this week that Sovos Compliance is this year's Tekne Award winner for innovation in the Established Software Companies category. The award recognized...

Boston Scientific Receives 2016 Shingo Prize for Operational Excellence

Boston Scientific today announced that its Cork, Ireland manufacturing facility has received the 2016 Shingo Prize for Excellence in Manufacturing from the Shingo Institute, part of the Jon M. Huntsman...

United States Remote Patient Monitoring Market - Outlook to 2022 - Key Vendors are Medtronic, Biotronik & Boston Scientific Corporation - Research and Markets

Research and Markets has announced the addition of the "United States Remote Patient Monitoring Market Outlook to 2022" report to their offering.

US Market Report for Neuromodulation Devices 2017 - MedCore

DescriptionMarket growth will be propelled by wider acceptance of neuromodulation products, allowing them to be used on a larger proportion of potential patients. In addition, many neuromodulation patients...

Boston Scientific (BSX) Reports Positive Data on HeartLogic

Boston Scientific (BSX) recently announced positive data from the first clinical trial on the HeartLogic Heart Failure Diagnostic Service to detect impending heart failure decompensation.

Boston Scientific To Participate In Piper Jaffray 2016 Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 28th Annual Piper Jaffray Healthcare Conference on November 29 in New York City.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary...

See More

Support & Resistance

2nd Resistance Point 20.98
1st Resistance Point 20.80
Last Price 20.61
1st Support Level 20.40
2nd Support Level 20.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.